Sort
39,280 grants matching “leukemia”
Collaborative Human Tissue Network (CHTN)
$774,914Nilsa Del Carmen Ramirez · Research Inst Nationwide Children'S Hosp · UM1 · FY2017 · CA
Engineering T cells to Promote Islet Transplant
$774,236James L Riley · University Of Pennsylvania · R01 · FY2024 · DK
Privileged and primitive hematopoietic stem cells, niches, and regulatory T cells
$774,122Joji Fujisaki · Beth Israel Deaconess Medical Center · R01 · FY2023 · HL
Privileged and primitive hematopoietic stem cells, niches, and regulatory T cells
$774,122Joji Fujisaki · Beth Israel Deaconess Medical Center · R01 · FY2022 · HL
Privileged and primitive hematopoietic stem cells, niches, and regulatory T cells
$774,122Joji Fujisaki · Beth Israel Deaconess Medical Center · R01 · FY2025 · HL
Type 1 Diabetes-A Proposal for Prevention & Intervention
$773,947Antoinette M Moran · University Of Minnesota · U01 · FY2009 · DK
Regulation of mRNA processing: Mechanisms and consequences
$773,516James L. Manley · Columbia Univ New York Morningside · R35 · FY2020 · GM
HDAC Inhibition to prevent GVHD
$773,323Pavan Reddy · University Of Michigan At Ann Arbor · P01 · FY2012 · CA
Molecular Profiling of Clinical Specimens
$773,292Paul S. Meltzer · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Novel DNA Repair Inhibitors for Cancer Therapy
$773,292Peter M Glazer · Yale University · R35 · FY2017 · CA
CPML - Project 2: Genome-wide Studies of ALL Drug Sensitivity
$772,488William E. Evans · St. Jude Children'S Research Hospital · P50 · FY2015 · GM
The Pathogenesis, Diagnosis, And Treatment Of Systemic Mast Cell Disorders
$771,523Dean D Metcalfe · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
SIGNALING PATHWAYS UTILIZED BY V-ABL AND BCR-ABL
$771,475Columbia University Health Sciences · P01 · FY2003 · CA
Protein Sequencing by Tandem Mass Spectrometry
$771,178University Of Virginia Charlottesville · R01 · FY2004 · GM
Engineering T cells to Promote Islet Transplant
$771,158James L Riley · University Of Pennsylvania · R01 · FY2025 · DK
Adoptive T cell Therapy for Pediatric Leukemia
$771,137Terry Fry · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
$771,133Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Building the foundations of commensal vaccines
$770,910Michael Andrew Fischbach · Stanford University · R01 · FY2023 · AI
Clinical Trials of Immunotherapies for Childhood Cancer
$770,902Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
CPML - Project 1: Genome-wide Studies of ALL Response
$770,856Charles G. Mullighan · St. Jude Children'S Research Hospital · P50 · FY2015 · GM
MCC Cord Blood Stem Cell Transplantation Study
$770,810Emmes Corporation · N01 · FY2001 · HB
Neurocognitive and Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell Therapy: A Controlled Comparison
$770,748Heather S.l. Jim · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
Immunobiology of Normal and Neoplastic Lymphocytes
$770,728Warren S Pear · University Of Pennsylvania · T32 · FY2024 · CA
CD300 receptors regulate efferocytosis, importance in inflammation, cancer and autoimmunity
$770,543John Coligan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Uterine signaling networks in the pathogenesis of pulmonary lymphangioleiomyomatosis (LAM)
$770,161Yan Xu · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · HL